Expert Insights

By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume3, Issue 1 “Pour some sugar on me” SGLT2 inhibitors have morphed into somewhat of a pharmacologic panacea over the last half-decade. First, there was the serendipitous discovery of cardio-protective effects in patients with…

Atrial fibrillation is a major health care disorder being the most common arrhythmia, is associated with low quality of life, increased risk of morbidity and mortality, and a very high cost burden.1 Advancing age and tobacco smoking, alcohol abuse, obesity, diabetes, myocardial infarction and heart…

By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 2, Issue 4 Recent data shows that despite all efforts from the heart failure community and in spite of contemporary guideline-directed medical therapy, deaths from heart failure (HF) continue to rise. The rates of death remain…

By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 2, Issue 3 Despite optimal medical therapy—which commonly consists of a cocktail of cardioprotective agents such as antiplatelet, statin, and antihypertensive medications—a significant number of patients with coronary artery…

By Yvette C Terrie, BS Pharm, RPh, consultant pharmacist It’s over one year later and COVID-19 is still part of all of our lives. Great strides have been made in learning more about the transmission, prevention and treatment of COVID-19. Moreover, many individuals are trying their best to get back…

Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication…

By Julie Gould Jeremy Kenter, DO, board-certified Emergency Medicine Physician and chief medical officer of Ally Medical Emergency Rooms, breaks down challenges in emergency medicine, and discusses Ally Medical ER—a system of emergency room facilities that are fully equipped to treat both minor…

By Julie Gould  Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed test means for the world of diagnostics in…

Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the vaccine supply increases, these additional…

By Julie Gould  Richard Miller, MD, board-certified oncologist and adjunct clinical professor of Medicine (oncology) at Stanford University Medical Center, discusses a trial examining the use of CPI-006, a humanized monoclonal antibody that is designed to bind to and activate B cells, for the…